Concepedia

Ui Beom Park

UB

Statistics

Publications

4

Citations

137

H-Index

4

Active since

2020

Affiliations

Konkuk University(Current)

Ui Beom Park is an author at Konkuk University specializing in immunotherapy, pharmacology, and cancer immunotherapy.

Publications per year

2020–2022

4

Publications

4

Crystal structure of PD-1 in complex with an antibody-drug tislelizumab used in tumor immune checkpoint therapy

Sang Hyung Lee, Hyun Tae Lee, Heejin Lim et al. · Biochemical and Biophysical Research Communications · 2020 · 36 citations

, , +16

Crystal structure of CD38 in complex with daratumumab, a first-in-class anti-CD38 antibody drug for treating multiple myeloma

Hyun Tae Lee, Yu-Jin Kim, Ui Beom Park et al. · Biochemical and Biophysical Research Communications · 2020 · 36 citations

, , +16

Molecular basis of PD-1 blockade by dostarlimab, the FDA-approved antibody for cancer immunotherapy

Ui Beom Park, Tae Jun Jeong, Nahyeon Gu et al. · Biochemical and Biophysical Research Communications · 2022 · 34 citations

, , +17

High-resolution structure of the vWF A1 domain in complex with caplacizumab, the first nanobody-based medicine for treating acquired TTP

Hyun Tae Lee, Ui Beom Park, Tae Jun Jeong et al. · Biochemical and Biophysical Research Communications · 2021 · 31 citations

, , +10

1–4 of 4